共 9 条
[1]
Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer[J]. Chang-Ming Huang, Jian-Xian Lin, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Bi-Juan Lin, Hui-Shan Lu, Department of Oncology, Aff iliated Union Hospital, Fujian Medical University, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China.World Journal of Gastroenterology. 2009(31)
[2]
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J] . Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.The Lancet . 2010 (9742)
[3]
Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication[J] . Maria D. Begnami,José Humberto T.G. Fregnani,Suely Nonogaki,Fernando A. Soares.Human Pathology . 2010 (8)
[5]
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J] . Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.Lancet Oncology . 2008 (3)
[8]
Indications of a minimized scope of lymphadenectomy for submucosal gastric cancer[J] . Shouji Shimoyama,Hidemitsu Yasuda,Kenichi Mafune,Michio Kaminishi.Annals of Surgical Oncology . 2002 (7)